Business Context and Reporting Period
DNA X, Inc. (Ticker: SONM) filed this Form 8-K on August 28, 2026, reporting a significant regulatory event regarding its listing status on The Nasdaq Stock Market LLC. The Company is incorporated in Delaware and maintains its principal executive offices in San Diego, California.
Key Financial Metrics
This filing does not contain specific financial statements, revenue figures, profit margins, cash flow data, or debt levels. The only financial metric referenced is the regulatory threshold for stockholders' equity, which is required to be at least $2.5 million under Nasdaq Listing Rule 5550(b)(1).
Material Changes
The primary material change reported is the Company's regained compliance with the Nasdaq Stockholders' Equity Requirement. On August 28, 2026, the Hearings Panel of Nasdaq determined that DNA X, Inc. has met the $2.5 million equity threshold. This decision reverses a prior deficiency, though the Company's securities remain subject to delisting if compliance is not maintained until November 18, 2026.
Outlook, Risks, and Contingencies
- Mandatory Monitoring: Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company is subject to a mandatory panel monitor for one year, ending August 28, 2027.
- Delisting Risk: If the Company falls out of compliance with the Stockholders' Equity Requirement during the monitoring period, it will not be permitted to submit a plan of compliance or receive additional cure time. Instead, Nasdaq Staff will issue a delisting determination letter immediately.
- Appeal Process: In the event of a delisting determination, the Company retains the right to request a new hearing with the Panel.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance to ensure it remains above the $2.5 million threshold.
- Monitor upcoming quarterly reports (10-Q) and annual reports (10-K) for any indications of equity erosion.
- Confirm the Company's continued adherence to all other Nasdaq Listing Rules through November 18, 2026.
- Review the Company's capital structure to understand how the equity requirement was met (e.g., capital raise, retained earnings, or asset revaluation).